12:00 AM
May 06, 2010
 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Acute promyelocytic leukemia (APL) Lysine-specific histone demethylase 1 (KDM1A; LSD1); KDM1B (LSD2) In...

Read the full 196 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >